Customise Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorised as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyse the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customised advertisements based on the pages you visited previously and to analyse the effectiveness of the ad campaigns.

No cookies to display.


National LTC Pharmacy Group Praises SFC Momentum on PBM Rebate Transparency

DATE: February 21, 2019

Washington, DC — Commenting on what appears to be developing momentum within the Senate Finance Committee for increased examination of pharmacy benefit manager (PBM) “rebate” transparency, the Senior Care Pharmacy Coalition (SCPC) today praised Chairman Charles Grassley’s (R-IA) reported positive sentiment regarding Ranking Member Ron Wyden’s (D-OR) “Creating Transparency to Have Drug Rebates Unlocked Act.”

Wyden’s bill, referred to as the “C-Thru Act,” would require PBMs to publicly disclose aggregate rebates they receive from drug makers and what percentage actually goes to Medicare beneficiaries. The bill would later require a minimum percentage of rebates be passed from PBMs to health plans and would base beneficiary cost-sharing in Medicare Part D on net prices.

Grassley said he plans to discuss Wyden’s C-THRU Act this session with the committee, a spokesman for the senator recently told Inside Health Policy. “Chairman Grassley has said PBMs lack transparency and how they work is too much of a mystery. Chairman Grassley agrees with many of the goals in Ranking Member Wyden’s legislation and will discuss it further within committee,” the Grassley spokesman said.

“SCPC is strongly supportive of bipartisan efforts to examine and reform the secretive, opaque PBM rebate system. Consistent with his longstanding commitment to transparency and oversight, we are encouraged by Chairman Grassley’s positive sentiment about further Committee discussion of C-Thru,” stated Alan G. Rosenbloom, President and CEO of SCPC, the only federal advocacy organization devoted exclusively to the interests of the nation’s long-term care (LTC) pharmacies and the patients they serve.

Rosenbloom also positively noted that Sen. John Cornyn (R-TX), another Senate Finance Committee member, recently announced on Twitter that a future topic of investigation for the committee would be abuses of the rebate system by PBMs.

####

The Senior Care Pharmacy Coalition (SCPC) is the only national organization exclusively representing the interests of LTC pharmacies. Its members operate in all 50 states and serve 825,000 patients daily in skilled nursing and assisted living facilities across the country. Visit seniorcarepharmacies.org  to learn more.

 

Recent Posts

Stay in the Know

Get the latest news and updates on issues impacting the long-term pharmacy community.

See Latest Updates